Cowen Assumes Lexicon Pharmaceuticals (LXRX) at Market Perform
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $1.71 --0%
Rating Summary:
3 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 11
Rating Summary:
3 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 11
Join SI Premium – FREE
Cowen assumed coverage on Lexicon Pharmaceuticals (NASDAQ: LXRX) with a Market Perform rating.
For an analyst ratings summary and ratings history on Lexicon Pharmaceuticals click here. For more ratings news on Lexicon Pharmaceuticals click here.
Shares of Lexicon Pharmaceuticals closed at $12.26 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Incyte (INCY) at Neutral, 'JAK-ing Up Its Pipeline In Advance of a Major Patent Cliff'
- Morgan Stanley Double Downgrades AU Optronics (2409:TT) (AUO) to Underweight
- TD Cowen Starts BellRing Brands (BRBR) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
